Development of a scalable and robust AEX method for enriched rAAV preparations in genome-containing VCs of serotypes 5, 6, 8, and 9

From National Research Council Canada

Download
  1. (PDF, 2.7 MiB)
  2. (PDF, 3.0 MiB)
DOIResolve DOI: https://doi.org/10.1016/j.omtm.2021.03.016
AuthorSearch for: ORCID identifier: https://orcid.org/0000-0003-4725-4916; Search for: 1; Search for: ORCID identifier: https://orcid.org/0000-0001-9405-4242; Search for: 1; Search for: 1; Search for: 1ORCID identifier: https://orcid.org/0000-0001-9110-8815
Affiliation
  1. National Research Council of Canada. Human Health Therapeutics
FunderSearch for: Canada Excellence Research Chairs; Search for: Natural Sciences and Engineering Research Council of Canada; Search for: National Research Council of Canada; Search for: Canada Research Chairs
FormatText, Article
SubjectAAV vectors; AAV serotype-5, 6, 8, 9; separation of genome containing/empty AAV capsids; anion-exchange chromatography; downstream processing; scale-up; gene therapy
Abstract
Publication date
PublisherElsevier
Licence
In
LanguageEnglish
Peer reviewedYes
IdentifierS2329050121000565
Export citationExport as RIS
Report a correctionReport a correction (opens in a new tab)
Record identifiera8dc1c6e-4e31-404c-a253-72ff1d864d95
Record created2023-01-09
Record modified2023-07-04
Date modified: